Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services
  • Trump Administration Secures New Supplies of Remdesivir for the United States

    HHS has secured more than 500,000 treatment courses of remdesivir by Gilead Sciences through September, the first authorized therapeutic for the treatment of COVID-19. The drug will be allocated by HHS to state health departments for purchase by American hospitals.




​PHE Newsroom

Submit an Inquiry


Watch, Listen, Subscribe

Facebook Twitter YouTube Email via GovDelivery LinkedIn ​​​
​​ ​​ ​​
  • This page last reviewed: July 01, 2020